OmniPathology Adopts PRIVIT Pass to Simplify Registration and Tracking of COVID-19 Test Results for Customers
New partnership that enables self-registration for COVID-19 testing and easy online access to test results is just in time for...
Month: August 2021
The ALS Association Massachusetts Chapter Announces Live Fall 2021 Ride to Defeat ALS and Walk to Defeat ALS Events
Annual Outdoor Events Offer Local Fundraising Teams New Activities and Opportunities to Raise Awareness for the DiseaseNORWOOD, Mass., Aug. 24, 2021...
Healthy Extracts Introduces Revolutionary On-the-Go Gel Packs of Clinically Proven Heart, Brain and Immune Health Formulations Using Patented Gel Technology
UBN ACTIVATE Gel-Pack UBN ACTIVATE Gel-Pack LAS VEGAS, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX) has...
HMNC Brain Health and Develco Pharma Partner to Initiate Ketamine Study Targeting Treatment-Resistant Depression (TRD)
Phase II Proof-of-Concept to study TRD patients resistant to standard antidepressantsMUNICH, Germany, Aug. 24, 2021 (GLOBE NEWSWIRE) -- HMNC Brain...
180 Life Sciences Corp. Announces Closing of $15.0 Million Private Placement
PALO ALTO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the...
Cassava Sciences Announces Agreement with FDA on Special Protocol Assessments (SPA) for its Phase 3 Studies of Simufilam for the Treatment of Alzheimer’s Disease
Phase 3 Study Initiation Still Expected Fall 2021AUSTIN, Texas, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA),...
Palisade Bio Reports Second Quarter Financial Results and Provides Business Update
CARLSBAD, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a late-stage biopharma company...
electroCore Announces New Reseller Agreement with Red One Medical Devices, LLC.
ROCKAWAY, NJ, Aug. 24, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced a...
Timber Pharmaceuticals Announces Last Patient Last Visit in Phase 2b CONTROL Study Evaluating TMB-001 in Moderate to Severe Congenital Ichthyosis
- Topline results expected to be announced in the fourth quarter of 2021 - - Company preparing for an End-of-Phase...
Greater Gift, AGTC, and 2020 On-site Partner To Honor & Celebrate Clinical Trial Participants and Provide Eye Exams to Underserved Children in the Local Community
WINSTON SALEM, N.C., Aug. 24, 2021 (GLOBE NEWSWIRE) -- Greater Gift of Winston Salem, a non-profit that celebrates participation in...
Alignment Healthcare Announces Special Blog Post on What Seniors Need to Know About Staying Safe, COVID-19 Vaccinations and the Delta Variant
ORANGE, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- As the pandemic continues with new concerns about the COVID-19 Delta variant,...
Solid Biosciences to Present at the 11th Annual World Orphan Drug Congress USA 2021
- Chief Operating Officer to discuss company’s advanced AAV gene therapy manufacturing capabilities and best practices for orphan drug development...
Alimera Sciences Announces National Pricing and Reimbursement Granted for ILUVIEN® for DME in Belgium
ATLANTA, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the...
Sight Sciences, Pioneering the Development of the Standalone MIGS Market, Announces Publication of Favorable Two-Year Outcomes of Standalone Use of the OMNI® Surgical System in Mild to Moderate Open-Angle Glaucoma
Real-world data published in Clinical Ophthalmology show the safety, efficacy, and durability of effect of OMNI for use in a...
CareCentrix Named 2021 Best Workplace for Aging Services by FORTUNE
HARTFORD, Conn., Aug. 23, 2021 (GLOBE NEWSWIRE) -- CareCentrix, the leader in health-at-home solutions, today announced the company’s inclusion in...
Bruce Binkowitz Joins Arcutis as Vice President of Biometrics
WESTLAKE VILLAGE, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing...
Solaris Pharma Receives Approval for First Generic Version of Clindagel® (clindamycin phosphate EQ 1%)
Solaris Pharma Receives Approval for First Generic Version of Clindagel Solaris Pharma Receives Approval for First Generic Version of Clindagel...
Spectral Medical Announces its Participation at Upcoming Investor Conferences
TORONTO, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic...
BriaCell to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021
NEW YORK and VANCOUVER, British Columbia, Aug. 23, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell”...
Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of COVID-19 Booster Vaccine
Based on successfully achieving certain milestones primarily related to the execution of a Phase 3 trial and development of large-scale...
